• Health & Medicine
• Science & Technology

News digest – cataloguing cancer genomes, gene-edited immune cells and NHS finances

In the news this week: scientists have completed the most comprehensive study of cancer genetics to date. In the news this week: scientists have completed the most comprehensive study of cancer genetics to date.

8 February 2020

• For Supporters

“Philanthropists will be younger and more diverse, and will want to see more evidence”: Chris Gethin on the future of major giving

Director of Philanthropy, Chris Gethin, shares his thoughts on what major giving will look like in 10 years’ time Director of Philanthropy, Chris Gethin, shares his thoughts on what major giving will look like in 10 years’ time

7 February 2020

• Health & Medicine

Targeted lung cancer treatment gets initial ‘no’ for NHS in England

Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua).  Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua). 

4 February 2020

• For Supporters

Partner Revolut is making donating easier than ever

To celebrate World Cancer Day, we explore how the FinTech company and some of our other partners are supporting the campaign To celebrate World Cancer Day, we explore how the FinTech company and some of our other partners are supporting the campaign

3 February 2020

• Health & Medicine
• Science & Technology

News digest – ex-smokers’ lungs, NHS staff shortages, Brexit and breast cancer genes

In the news this week: protective cells lining the lungs of ex-smokers could explain why quitting smoking reduces lung cancer risk. In the news this week: protective cells lining the lungs of ex-smokers could explain why quitting smoking reduces lung cancer risk.

1 February 2020

• Health & Medicine

What happens after Brexit and what could it mean for cancer?

At 11pm on Friday 31st January, the UK will leave the European Union. And the big question is – what happens next? At 11pm on Friday 31st January, the UK will leave the European Union. And the big question is – what happens next?

31 January 2020

• Health & Medicine

Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers

Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer. Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer.

29 January 2020

• Health & Medicine

NHS staff shortages mean patients miss out on early bowel cancer diagnosis

Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages. Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages.

28 January 2020

• Health & Medicine
• Science & Technology

News digest – cervical cancer progress, new immune cell, breast cancer scans and repurposed drugs

In the news this week:  cervical cancer progress in Britain has stalled in the last decade, as screening uptake remains stubbornly low. In the news this week:  cervical cancer progress in Britain has stalled in the last decade, as screening uptake remains stubbornly low.

25 January 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Health & Medicine

Cervical cancer progress falters as screening uptake hits record lows

Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating. Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating.

22 January 2020